Effect of once-daily FDC treatment era on initiation of cART
David M Mosen1, Michael Horberg2, Douglas Roblin3, Christina M Gullion1, Richard Meenan1, Wendy Leyden2, Weiming Hu11Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA; 2Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA; 3Center for Health Research...
Guardado en:
Autores principales: | David M Mosen, Michael Horberg, Douglas Roblin, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fd8c89ed7cbc4950aa8bf2d39f66cba0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Potential benefit of dolutegravir once daily: efficacy and safety
por: Fantauzzi A, et al.
Publicado: (2013) -
Clinical utility and consumer considerations for the use of once-daily nevirapine extended release for HIV infection treatment
por: Pefura Yone EW, et al.
Publicado: (2012) -
New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir
por: Patel N, et al.
Publicado: (2012) -
Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
por: Navarro J, et al.
Publicado: (2016) -
An update on the use of Atripla® in the treatment of HIV in the United States
por: Michael A Horberg, et al.
Publicado: (2010)